<DOC>
	<DOCNO>NCT01916980</DOCNO>
	<brief_summary>This efficacy safety study 12 week desloratadine Japanese participant eczema/dermatitis dermal pruritus . The primary hypothesis study sum daytime nighttime pruritus/itch score eczema/dermatitis group dermal pruritus group significantly improve Week 2 compare Baseline .</brief_summary>
	<brief_title>Efficacy Safety Study Desloratadine ( MK-4117 ) Japanese Participants With Eczema/Dermatitis Dermal Pruritus ( MK-4117-202 )</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<criteria>Eczema/dermatitis ( acute eczema , chronic eczema , contact dermatitis , atopic dermatitis , nummular eczema , seborrheic dermatitis , asteatotic eczema , neurodermatitis , etc . among eczema/dermatitis observation pruritus appropriate ) Dermal pruritus ( generalize dermal pruritus , localize dermal pruritus ) Hypersensitivity antihistamines ingredient study drug</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Dermatitis</keyword>
	<keyword>Dermatitis , Atopic</keyword>
	<keyword>Skin Diseases</keyword>
	<keyword>Skin Diseases , Genetic</keyword>
	<keyword>Genetic Diseases , Inborn</keyword>
	<keyword>Skin Diseases , Eczematous</keyword>
	<keyword>Hypersensitivity , Immediate</keyword>
	<keyword>Hypersensitivity</keyword>
	<keyword>Immune System Diseases</keyword>
</DOC>